TechInvention Sets Benchmark for Automated and Digitalized Vaccine Manufacturing Processes
TechInvention is committed to advancing vaccine technologies by continually developing and enhancing cutting-edge platforms, including recombinant protein, conjugate, OMV-based, and mRNA vaccines, states Syed Ahmed, CEO, TechInvention in his interview with Aishwarya Saxena, Pharma Industrial India.
TechInvention | 16/08/2024
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy